Correspondence 0001104659-23-107370 from ESSA Pharma Inc. (EPIX) (CIK 0001633932)
ESSA Pharma Inc. (EPIX) (CIK 0001633932)
Date: Oct. 6, 2023 · CIK: 0001633932 · Accession: 0001104659-23-107370
AI Filing Summary & Sentiment
File numbers found in text: 333-274584
Show Raw Text
CORRESP
1
filename1.htm
October
6, 2023
VIA EDGAR
United States
Securities and Exchange Commission
Division of Corporation
Finance
Office of Life
Sciences
100 F Street,
N.E.
Washington, DC
20549-3561
Attn: Daniel
Crawford
Alan
Campbell
Re: ESSA Pharma Inc.
Registration Statement on Form S-3 (File No. 333-274584)
Ladies and Gentlemen:
On
behalf of ESSA Pharma Inc. (the “Company”), we respectfully request that the U.S. Securities
and Exchange Commission take appropriate action to accelerate the effective date of the Registration Statement on Form S-3 (File No.
333-274584) (the “Registration Statement”) pursuant to Rule 461 under the Securities Act of 1933, as amended, so that the
Registration Statement will be declared effective at 4:00 p.m. Eastern Time on October 10, 2023 or as soon thereafter as is practicable.
We
also request that the undersigned of Skadden, Arps, Slate, Meagher & Flom LLP, the Company’s counsel, be notified of such effectiveness
by a telephone call at (212) 735-2227 and that such effectiveness also be confirmed in writing.
Very truly yours,
/s/ Michael J.
Hong
Michael J. Hong
cc: David Parkinson